ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common Shares

Bitget2026/10/21 20:50

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ADAR1 Capital Management reported purchases of 922,849 Tenax Therapeutics common shares, increasing reported indirect beneficial ownership to 7,447,000 shares.
Daniel Schneeberger, ADAR1’s manager, also reported indirect beneficial ownership. Both reporting owners are listed as 10% owners.
Purchases comprised 336,528 shares at $1.5066, 254,342 shares at $1.5952 and 331,979 shares at $1.6588.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000027), on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common Shares

You may also like

Crypto prices